Table 2.
Comorbidities at enrolment
| n (%) | |
|---|---|
| N of patients with at least one comorbidity | 171 (81.8) |
| Anxiety/depression | 12 (5.7) |
| Arterial hypertension | 103 (49.3) |
| Atherothrombotic disease, including coronary heart disease | 27 (12.9) |
| Atrial fibrillation | 9 (4.3) |
| Benign prostatic hypertrophy | 25 (12.0) |
| Cerebrovascular disease (carotid stenosis, stroke) | 13 (6.2) |
| Deep venous thrombosis (DVT) | 1 (0.5) |
| Diabetes mellitus | 45 (21.5) |
| Emphysema | 8 (3.8) |
| Gastroesophageal reflux disease | 49 (23.4) |
| Hypercholesterolaemia | 17 (8.1) |
| Lung cancer | 1 (0.5) |
| Peripheral arterial disease (symptomatic or ankle brachial index < 0.8) | 2 (1.0) |
| Pulmonary hypertension | 6 (2.9) |
| Renal insufficiency | 5 (2.4) |
| Other | 80 (38.3) |
| Previous myocardial infarction | 23 (11.0) |
Percentages calculated out of total number of evaluable patients. A patient could have more than one comorbidity